The DKK1 Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Ca Ski human cervical adenocarcinoma cell line, engineered to disrupt the DKK1 gene. This product format provides a heterogeneous pool of cells harboring targeted gene disruptions, offering a robust loss-of-function model for studying DKK1-dependent signaling without isolation of single-cell clones. The polyclonal nature maintains biological variability while ensuring consistent knockout across the population, making it suitable for experiments where clonal artifacts are undesirable. The cells are available as a ready-to-use reagent for immediate application in Wnt pathway analysis, cancer biology, and drug discovery research.
Ca Ski cells originate from a metastatic cervical carcinoma and are characterized by their adherent epithelial morphology and stable integration of HPV-16 sequences, including active expression of the E6 and E7 oncoproteins. This genetic background drives p53 and retinoblastoma protein inactivation, contributing to immortalization and a transformed phenotype. As a widely accepted model for HPV-associated cervical cancer, Ca Ski cells recapitulate key aspects of tumor biology, including aberrant proliferation, resistance to apoptosis, and altered signaling networks. Their use in knockout studies allows dissection of molecular pathways that intersect with HPV oncogenesis and host cell regulatory mechanisms.
DKK1 encodes a secreted glycoprotein that functions as a potent antagonist of canonical Wnt/??-catenin signaling. Mechanistically, DKK1 simultaneously binds the Wnt co-receptors LRP5 and LRP6 and the transmembrane Kremen proteins (Kremen1 and Kremen2), inducing rapid internalization of LRP5/6 and preventing formation of functional Wnt?CFrizzled?CLRP5/6 signalosomes. This sequestration blocks Wnt ligand-mediated signal transduction, leading to ??-catenin degradation via the destruction complex and reduced transcription of TCF/LEF-dependent target genes. Key downstream targets subject to DKK1-mediated repression include MYC, CCND1, and AXIN2. DKK1 itself is transcriptionally regulated by ??-catenin/TCF, establishing a negative feedback loop, and is further controlled by upstream factors such as p53 and TGF-??.
In the Ca Ski cervical cancer context, loss of DKK1 expression can profoundly alter Wnt pathway activity, with implications for tumor growth, invasion, and metastatic potential. Ectopic Wnt activation resulting from DKK1 knockout may collaborate with HPV oncoproteins to enhance proliferative and migratory capacities, providing a valuable system to study the interplay between viral transformation and developmental signaling pathways. This model is particularly relevant for investigating mechanisms of bone metastasis, where DKK1 is a known regulator of osteoblast differentiation and osteolytic lesion formation. Researchers can use these cells to explore how DKK1 influences epithelial?Cmesenchymal transition, stemness, and therapeutic resistance in HPV-positive tumors.
Typical research applications for these polyclonal knockout cells encompass a broad range of functional assays to interrogate Wnt/??-catenin signaling dynamics. Measurement of ??-catenin protein levels by western blotting, TCF/LEF luciferase reporter activity, and RT-qPCR analysis of target gene expression (e.g., MYC, CCND1, AXIN2) directly report on pathway activation status. Immunofluorescence staining for ??-catenin nuclear localization, along with migration and apoptosis assays, enables detailed phenotyping of the knockout impact. These cells support studies in cervical cancer pathogenesis, bone biology, and drug screening for Wnt pathway modulators. For further details or technical inquiries, please contact Ascent Research.
